Medication info
Valsartan Tablet (Valsartan)

Valsartan Tablet (Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tablet
Manufacturer / importer
Gunil Biopharm Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202003314 · Approved 2020.05.07 · Insurance code 073000690

Summary

Main use
Treatment of essential hypertension and heart failure; reduction of the risk of death after myocardial infarction
Who takes it
Adults · Children
Adult dose
* 40, 80, 160 mg 1. Essential hypertension Take with water during or between meals. It is recommended that the medication be taken at the same time each day, if possible (e.g., in the morning). 1) Adults: The recommended dose is 80 mg of valsartan orally once a day, regardless of sex or race. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg per day or a diuretic may be administered concomitantly. If further blood pressure reduction is needed, the dose may be increased to a maximum of 320 mg per day. 2) Older adults (75 years and older): Start with 40 mg of this medication once a day. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is necessary. (2) Creatinine clearance 10 ∼ 20 mL/min: Start with 40 mg of this medication once a day. (3) Creatinine clearance less than 10 mL/min and patients on dialysis: Do not administer this medication. 4) Patients with reduced body fluid volume: For patients with reduced body fluid volume (e.g., patients taking high doses of diuretics whose dose cannot be reduced), start with 40 mg of this medication once a day. 5) Patients with hepatic impairment: For patients with mild or moderate hepatic impairment, start treatment with 40 mg of this medication once a day and do not exceed 80 mg per day. Do not administer this medication to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended starting dose is 40 mg of this medication per dose, 2 times a day orally, and it may be increased to 80 mg or 160 mg per dose. When administered with a diuretic, consider reducing the diuretic dose. The maximum daily dose is 320 mg, administered in divided doses. Triple combination therapy of this medication with an ACE inhibitor and a beta blocker is not recommended. 3. Reduction of the risk of death after myocardial infarction Adults: Treatment may be started within 12 hours of the onset of myocardial infarction. The recommended starting dose is 20 mg of this medication per dose, 2 times a day. Thereafter, over several weeks, increase the dose according to the patient's tolerability, administering 40 mg, 80 mg, and 160 mg per dose 2 times a day. Consider dose reduction if symptoms of hypotension or renal failure occur. This medication may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytic agents, acetylsalicylic acid, beta blockers, and statins). However, concomitant use with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary for creatinine clearance of 10 mL/min or higher. However, do not administer this medication to patients with creatinine clearance less than 10 mL/min or patients on dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of this medication should preferably not exceed 80 mg. If administering more than 80 mg per day, consider whether the benefits of treatment outweigh the risks when increasing the dose. Do not administer this medication to patients with severe hepatic impairment, cirrhosis, or cholestasis.
Child dose
1. Essential hypertension: 6) Children: Safety and efficacy have not been established in children and adolescents under 18 years of age. 6. Children: Safety and efficacy have not been established in children and adolescents under 18 years of age.

Ingredients

Manufacturer
Gunil Biopharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure; reduction of the risk of death after myocardial infarction

  • Essential hypertension
  • heart failure
  • left ventricular dysfunction
  • left ventricular systolic dysfunction.
View approved original text

This medication is used to treat essential hypertension and heart failure. It can also be used for heart failure patients who have intolerance to ACE inhibitors. Additionally, it helps reduce the risk of death in patients with left ventricular dysfunction after myocardial infarction. Therefore, it plays an essential role in improving survival rates through blood pressure control and enhancement of cardiac function. This medication is used for the management of hypertension and heart failure and to reduce post-myocardial infarction risks.

How to take

Adult dose

* 40, 80, 160 mg 1. Essential hypertension Take with water during or between meals. It is recommended that the medication be taken at the same time each day, if possible (e.g., in the morning). 1) Adults: The recommended dose is 80 mg of valsartan orally once a day, regardless of sex or race. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg per day or a diuretic may be administered concomitantly. If further blood pressure reduction is needed, the dose may be increased to a maximum of 320 mg per day. 2) Older adults (75 years and older): Start with 40 mg of this medication once a day. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is necessary. (2) Creatinine clearance 10 ∼ 20 mL/min: Start with 40 mg of this medication once a day. (3) Creatinine clearance less than 10 mL/min and patients on dialysis: Do not administer this medication. 4) Patients with reduced body fluid volume: For patients with reduced body fluid volume (e.g., patients taking high doses of diuretics whose dose cannot be reduced), start with 40 mg of this medication once a day. 5) Patients with hepatic impairment: For patients with mild or moderate hepatic impairment, start treatment with 40 mg of this medication once a day and do not exceed 80 mg per day. Do not administer this medication to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended starting dose is 40 mg of this medication per dose, 2 times a day orally, and it may be increased to 80 mg or 160 mg per dose. When administered with a diuretic, consider reducing the diuretic dose. The maximum daily dose is 320 mg, administered in divided doses. Triple combination therapy of this medication with an ACE inhibitor and a beta blocker is not recommended. 3. Reduction of the risk of death after myocardial infarction Adults: Treatment may be started within 12 hours of the onset of myocardial infarction. The recommended starting dose is 20 mg of this medication per dose, 2 times a day. Thereafter, over several weeks, increase the dose according to the patient's tolerability, administering 40 mg, 80 mg, and 160 mg per dose 2 times a day. Consider dose reduction if symptoms of hypotension or renal failure occur. This medication may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytic agents, acetylsalicylic acid, beta blockers, and statins). However, concomitant use with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary for creatinine clearance of 10 mL/min or higher. However, do not administer this medication to patients with creatinine clearance less than 10 mL/min or patients on dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of this medication should preferably not exceed 80 mg. If administering more than 80 mg per day, consider whether the benefits of treatment outweigh the risks when increasing the dose. Do not administer this medication to patients with severe hepatic impairment, cirrhosis, or cholestasis.

Child dose

1. Essential hypertension: 6) Children: Safety and efficacy have not been established in children and adolescents under 18 years of age. 6. Children: Safety and efficacy have not been established in children and adolescents under 18 years of age.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with an allergy to this medication or those with severe liver or kidney impairment should not take it. Elderly patients or those with elevated serum potassium levels, as well as patients with mild to moderate liver impairment, should use this medication with caution and may require dose adjustments. Patients with heart failure or those after myocardial infarction should have regular kidney function tests while using this medication, as there can be risks of hypotension or worsening kidney function. In the early stages of treatment, blood pressure may drop too low, causing dizziness or fainting; therefore, it is recommended to start at a low dose and gradually increase, especially in cases of fluid or sodium depletion. Since this medication can increase potassium levels, serum potassium levels should be monitored frequently when used in conjunction with potassium supplements or potassium-sparing diuretics. Caution should be exercised when taking this medication alongside non-steroidal anti-inflammatory drugs (NSAIDs), as it can reduce the blood pressure-lowering effect and worsen kidney function. When used with lithium preparations, toxicity may occur due to increased lithium levels; hence, serum lithium levels should be monitored. This medication may cause dizziness when driving or operating machinery, so caution is necessary. Side effects may include headache, dizziness, fatigue, cough, diarrhea, etc., and serious adverse reactions such as angioedema, hepatitis, or kidney failure can occur rarely; immediate consultation with healthcare personnel is needed if symptoms arise. This medication should not be used in children and adolescents, as safety and efficacy have not been established. In case of overdose, severe hypotension, decreased consciousness, or shock may occur, requiring immediate treatment at a hospital. Store this medication in a place out of reach of children, and do not transfer it to other containers as a safety measure.

Side effects

headache

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture and should be stored in a tightly sealed container. To maintain its efficacy, avoid direct sunlight and high temperatures, and it is recommended to store it in a cool place below 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.